Lv1
86 积分 2026-04-07 加入
Real-world effectiveness and safety of firsekibart versus compound betamethasone in frequent gout flares: a multicenter retrospective study
1天前
已完结
Glucagon-Like Peptide-1 Receptor Agonists Use Does Not Increase the Risk for Acute Pancreatitis and Is Associated With Lower Complications in Patients With Type 2 Diabetes Who Develop Acute Pancreatitis: A Multicenter Analysis
9天前
已完结
Teprotumumab-Related Adverse Events in Thyroid Eye Disease: A Multicenter Study
29天前
已完结
Assessment of Hearing Dysfunction in Patients With Graves’ Disease and Thyroid Eye Disease Without or With Teprotumumab
29天前
已完结
Teprotumumab-Associated Hyperglycemia: A Large-Scale Multinational Cohort Study
29天前
已完结
Postmarketing Safety Concerns of Teprotumumab: A Real-World Pharmacovigilance Assessment
29天前
已完结
Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database
29天前
已完结
An observational study on the safety of teprotumumab based on FAERS database
29天前
已完结
Lipoprotein(a) Reduction with Inclisiran, Alirocumab, Evolocumab, Enlicitide and Lerodalcibep: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
2个月前
已完结
Glucagon-Like Peptide-1 Receptor Agonists Use Does Not Increase the Risk for Acute Pancreatitis and Is Associated With Lower Complications in Patients With Type 2 Diabetes Who Develop Acute Pancreatitis: A Multicenter Analysis
4个月前
已完结
皖公网安备34019202002308
